These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34549178)

  • 1. Symptomatic peduncular, cavernous bleeding following SARS-CoV-2 vaccination induced immune thrombocytopenia.
    Finsterer J; Redzic Z
    Brain Hemorrhages; 2021 Dec; 2(4):169-171. PubMed ID: 34549178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Severe thrombocytopenia after COVID-19 mRNA vaccination].
    Hagihara M; Uchida T; Inoue M; Ohara S; Imai Y
    Rinsho Ketsueki; 2021; 62(12):1684-1687. PubMed ID: 35022337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group.
    González-López TJ; Bárez A; Bernardo-Gutiérrez A; Bernat S; Canaro-Hirnyk M; Entrena-Ureña L; Fernández-Fuertes F; Guinea de Castro JM; Jiménez-Bárcenas R; Pascual-Izquierdo C; Sánchez-González B; Jarque I
    Infect Dis Ther; 2023 Feb; 12(2):303-315. PubMed ID: 36520323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
    J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case of Immune Thrombocytopenia After BNT162b2 mRNA COVID-19 Vaccination.
    King ER; Towner E
    Am J Case Rep; 2021 Jul; 22():e931478. PubMed ID: 34285180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
    Matsumura A; Katsuki K; Akimoto M; Sakuma T; Nakajima Y; Miyazaki T; Fujisawa S; Nakajima H
    Rinsho Ketsueki; 2021; 62(11):1639-1642. PubMed ID: 34866090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination.
    Portuguese AJ; Sunga C; Kruse-Jarres R; Gernsheimer T; Abkowitz J
    Blood Adv; 2021 Jul; 5(13):2794-2798. PubMed ID: 34255033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune thrombocytopenia associated with COVID-19 mRNA vaccine tozinameran - a clinical case and global pharmacovigilance data.
    Battegay R; Istampoulouoglou I; Holbro A; Buser A; Hirsiger JR; Eckstein J; Berger CT; Koechlin S; Leuppi-Taegtmeyer AB
    Swiss Med Wkly; 2021 Dec; 151():w30084. PubMed ID: 34908388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Thrombocytopenia in Previously Healthy Individuals Following SARS-CoV-2 Vaccination (COVID-19 Immunization): A Descriptive Research of 70 Instances With a Focus on Biomarkers, Predictive Outcomes, and Consequences.
    Sharma K; Patel S; Patel Z; Patel KB; Shah DB; Doshi J; Chokshi P; Sharma C; Amdani MM; Parabtani A; Benani U; Konat A
    Cureus; 2022 Jul; 14(7):e26480. PubMed ID: 35923492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Thrombocytopenic Purpura following Administration of mRNA-Based SARS-CoV-2 and MMR Vaccinations: A Cautionary Tale.
    Thomas W; Albano A; Kirkel D; Rouhizad N; Arinze F
    Case Rep Infect Dis; 2021; 2021():2704249. PubMed ID: 34635874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very severe immune thrombocytopenia following SARS-CoV-2 vaccination requiring splenectomy: a case report.
    Weiner M; Rodriguez-Vigouroux R; Masouridi-Levrat S; Samii K
    Thromb J; 2022 Aug; 20(1):45. PubMed ID: 35996108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine.
    Finsterer J; Korn M
    Brain Hemorrhages; 2021 Dec; 2(4):165-167. PubMed ID: 34192245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Thrombocytopenia Exacerbation After COVID-19 Vaccination in a Young Woman.
    Fujita M; Ureshino H; Sugihara A; Nishioka A; Kimura S
    Cureus; 2021 Sep; 13(9):e17942. PubMed ID: 34660131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
    Cooper KM; Switzer B
    Arch Clin Cases; 2021; 8(2):31-36. PubMed ID: 34754937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of thrombocytopenic purpura following BNT162b2 mRNA COVID-19 vaccination].
    Shibata K; Tanaka H; Otani A; Kubo M; Hasegawa A; Amano I
    Rinsho Ketsueki; 2021; 62(10):1519-1521. PubMed ID: 34732627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.
    Fueyo-Rodriguez O; Valente-Acosta B; Jimenez-Soto R; Neme-Yunes Y; Inclán-Alarcón SI; Trejo-Gonzalez R; García-Salcido MÁ
    BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34059544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune thrombocytopenia relapse post covid-19 vaccine in young male patient.
    Qasim H; Ali E; Yassin MA
    IDCases; 2021; 26():e01344. PubMed ID: 34804803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurosurgical Considerations Regarding Decompressive Craniectomy for Intracerebral Hemorrhage after SARS-CoV-2-Vaccination in Vaccine Induced Thrombotic Thrombocytopenia-VITT.
    Gessler F; Schmitz AK; Dubinski D; Bernstock JD; Lehmann F; Won SY; Wittstock M; Güresir E; Hadjiathanasiou A; Zimmermann J; Miesbach W; Freiman T; Vatter H; Schuss P
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34202817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.